千红制药：2024年净利润3.56亿元，同比增长95.77%

Core Insights - The company reported a revenue of 1.526 billion yuan for 2024, representing a year-on-year decline of 15.88% [1] - The net profit attributable to shareholders increased to 356 million yuan, showing a significant year-on-year growth of 95.77% [1] - The board approved a profit distribution plan, proposing a cash dividend of 1.2 yuan per 10 shares (including tax), based on a total of 1.25 billion yuan, with no bonus shares issued [1]